Home    Back

Dysport® (botulinumtoxin a (btx a))    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
36Epidermolysis bullosa1

36. Epidermolysis bullosa    [ 147 clinical trials,   170 drugs,   (DrugBank: 40 drugs),   32 drug target genes,   113 drug target pathways]
Searched query = "Epidermolysis bullosa", "EBS", "JEB", "DDEB", "RDEB", "Kindler syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 147 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00936533
(ClinicalTrials.gov)		May 20098/7/2009Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia CongenitaBotulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita - a Double-blind Placebo-controlled Phase II Proof of Concept StudyEpidermolysis Bullosa SimplexDrug: Dysport® (Botulinumtoxin A (Btx A));Drug: PlaceboUppsala UniversityNULLRecruiting16 YearsN/ABoth40Phase 2Sweden